REGENXBIO Inc. Business Operations Contracts & Agreements
6 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Cooperation Agreements (1)
- Development Agreements (2)
- Sales Agreements (1)
- Settlement Agreements (1)
- ATM Equity OfferingSM Sales Agreement, dated as of September 1, 2023, between BofA Securities, Inc. and REGENXBIO Inc (Filed With SEC on September 1, 2023)
- Settlement Agreement and Mutual Release dated November 12, 2021 between the Registrant and Abeona Therapeutics Inc (Filed With SEC on March 1, 2022)
- Collaboration and License Agreement dated September 10, 2021 between the Company and AbbVie Global Enterprises Ltd (Filed With SEC on November 2, 2021)
- CONFIDENTIAL TREATMENT REQUESTED DEVELOPMENT, MANUFACTURING, AND TESTING STANDARD TERMS AND CONDITIONS (Filed With SEC on September 15, 2015)
- CONFIDENTIAL TREATMENT REQUESTED COOPERATION AGREEMENT (Filed With SEC on August 17, 2015)
- CONFIDENTIAL TREATMENT REQUESTED DEVELOPMENT, MANUFACTURING, AND TESTING STANDARD TERMS AND CONDITIONS (Filed With SEC on August 17, 2015)
